# The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

> **NCT07077811** · NA · ENROLLING_BY_INVITATION · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 158 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Heart Failure
- Atrial Fibrillation (AF)
- HFpEF - Heart Failure With Preserved Ejection Fraction

## Interventions

- **PROCEDURE:** pulsed field ablation
- **DRUG:** antiarrhythmic drug

## Key facts

- **NCT ID:** NCT07077811
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07077811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07077811, "The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07077811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*